Archive

DES MOINES, Iowa, U.S. (April 18, 2024) – Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has received Novel Food authorization from the European Commission for BetaVia^™ Pure, along with a five-year exclusivity in the European Union.¹

BetaVia Pure is manufactured through a patented process using Euglena gracilis—Kemin’s proprietary strain of the algae. The 95% beta 1,3 glucan (paramylon) ingredient for immune and gut support is the highest purity beta-glucan currently available on the market.^2-5 With its neutral odor, colour, and small recommended dose, the postbiotic can be included in numerous finished-product forms and easily included as part of a daily health routine.

Effective April 30, 2024, the Commission Implementing Regulation authorizes BetaVia Pure to be placed on the market in specific food categories. Kemin Human Nutrition and Health’s comprehensive proprietary data establishing the safety of BetaVia Pure led to a five-year exclusivity in the European Union market.

The Novel Food authorization includes usage in food supplements for a range of age groups—from children three years of age up to adulthood—and allows for BetaVia Pure to be used in diet replacements for weight control and cereal bars for the general population.

"The European Food Safety Authority conducted an extremely rigorous evaluation of the safety data on BetaVia Pure, and now receiving approval is a tremendous achievement that demonstrates the strength of the Novel Food dossier Kemin Human Nutrition and Health submitted to the European Commission," said Pedro Vieira, Vice President – Europe, Kemin Human Nutrition and Health. "We are extremely excited to see the Commission Implementing Regulation published, which finally allows us to offer BetaVia Pure to the European Union, one of the key markets for Kemin Human Nutrition and Health."

BetaVia has an established global regulatory status, including in the U.S., Brazil, Japan, China, and many other countries. Kemin Human Nutrition and Health’s naturally sourced solutions are GRAS, kosher, halal, vegetarian, gluten free, allergen free, and non-GMO.

Click here to read the authorization, and click here for more information on formulating with BetaVia for better immune and gut support.

###

About Kemin Industries
Kemin Industries (www.kemin.com) is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies, textile, biofuel, and animal vaccine industries.

For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety, and efficacy of food, feed, and health-related products.

Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 3,000 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, Egypt, India, Italy, San Marino, Singapore, South Africa, and the United States.

Media Contact:
Carrie Livingston, VP of Media Relations, ColinKurtis | carrie@colinkurtis.com, +1 815 519 8302

REFERENCES:
¹Commission Implementing Regulation (EU) 2024/1046 of 9 April 2024 authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food and amending Implementing Regulation (EU) 2017/2470 - C/2024/2138
²Kemin, BetaVia can prime key cells in the innate immune system. KHTL-017-150.
³KHTL-017-160 Paramylon Improves Antioxidant Status and Metabolic Health
⁴Kemin Proprietary Data TD-20-6867 “Effect of a Euglena gracilis (β-1,3-glucan) on Gut and Immune Health in Healthy Adults with Mild Gastrointestinal (GI) Issues.”
⁵Patents granted a patent on beta 1,3 glucans for modulating immune function (US Patent 10,912,794).  This new patent joins a previously issued patent, US 9574217, on the production of immune modulation using algae from a proprietary strain of Euglena gracilis ATCC PTA-123017